|
|
|
|
|
|
-
Valeant Pharmaceuticals Announces Resignation Of Laurence Paul From Board Of Directors
5/15/2013
|
|
|
-
Hyperion Therapeutics Exercises Option To Acquire Rights To BUPHENYL(R) And AMMONUL(R)
5/2/2013
|
|
|
|
|
-
Valeant Pharmaceuticals International (VRX.TO) Has Raised Its FY13 EPS Estimate To 5.55 - 5.85 From 5.45 - 5.75
5/2/2013
|
-
Valeant Pharmaceuticals Posts Q1 Loss Per Share Of $0.09 Vs. Loss $0.04 Year Ago
5/2/2013
|